Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

· cnbc.com

Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.

Novo Nordisk on Tuesday filed a lawsuit against Eli Lilly , alleging that its advertising campaigns for its blockbuster obesity and diabetes drugs are designed ...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI